gene,hugoGene,hgnc_id,entrez_id,msEntrez,ensembl_gene_id,dn.ptv,dn.misa,dn.misb,dbs.case.ptv,dbs.control.ptv,sweden.case.ptv,sweden.control.ptv,case.ptv,control.ptv,mut.ptv,mut.misa,mut.misb,pLI,qval_dnccPTV,pval_dnccPTV,ASD_vs_DDID,Function,Category,OMIM_Phenotype,Other databases (NR if AD neurodevelopmental phenotype in OMIM),Relevant Literature (NR if AD neurodevelopmental phenotype in OMIM or other databases. Excludes published variants analyzed in this study.),De Rubeis 2014,Sanders 2015,Yuen 2017,DDD 2017
CHD8,CHD8,HGNC:20153,57680,223691,ENSG00000100888,11,3,5,2,0,0,0,2,0,1.40890469095966e-05,1.88937714434016e-05,2.54618390166457e-05,0.999999999998095,0,2.85959393766085e-07,ASD,Gene expression regulation,Known NDD gene (AD),"{Autism, susceptibility to, 18} (AD)",NR,NR,FDR ≤ 0.01,FDR ≤ 0.01,Yes,Yes
SCN2A,SCN2A,HGNC:10588,6326,224796,ENSG00000136531,9,2,11,3,0,0,0,3,0,8.69547596516122e-06,2.24870916258667e-05,2.32960453629503e-05,0.999999992314383,0,2.85959393766085e-07,DDID,Neuronal communication,Known NDD gene (AD),"Epileptic encephalopathy, early infantile, 11 (AD); Seizures, benign familial infantile, 3 (AD)",NR,NR,FDR ≤ 0.01,FDR ≤ 0.01,Yes,Yes
SYNGAP1,SYNGAP1,HGNC:11497,8831,12583,ENSG00000197283,10,1,3,4,0,0,0,4,0,6.47097000711382e-06,1.85395361121603e-05,2.93923286942259e-05,0.999998449747972,0,2.85959393766085e-07,DDID,Neuronal communication,Known NDD gene (AD),"Mental retardation, autosomal dominant 5 (AD)",NR,NR,FDR ≤ 0.01,FDR ≤ 0.01,Yes,Yes
ADNP,ADNP,HGNC:15766,23394,236899,ENSG00000101126,9,0,0,2,0,1,0,3,0,3.88417474984174e-06,0,0,0.9989040999292,8.52096171399808e-15,2.85959393766085e-07,DDID,Gene expression regulation,Known NDD gene (AD),Helsmoortel-van der Aa syndrome (AD),NR,NR,FDR ≤ 0.01,FDR ≤ 0.01,Yes,Yes
FOXP1,FOXP1,HGNC:3823,27086,18992,ENSG00000114861,6,0,3,0,1,0,0,0,1,4.3870560147036e-06,6.8378245584836e-06,2.96805214687825e-06,0.999750735055125,1.77220460528815e-12,2.85959393766085e-07,DDID,Gene expression regulation,Known NDD gene (AD),Mental retardation with language impairment and with or without autistic features (AD),NR,NR,.,0.01 < FDR ≤ 0.05,Yes,Yes
POGZ,POGZ,HGNC:18801,23126,140630,ENSG00000143442,6,1,0,4,0,2,0,6,0,7.00243949364294e-06,2.27834301233688e-05,2.56342023522554e-06,0.999999128125461,1.09266836319695e-10,2.85959393766085e-07,DDID,Gene expression regulation,Known NDD gene (AD),White-Sutton syndrome (AD),NR,NR,FDR ≤ 0.01,FDR ≤ 0.01,Yes,Yes
ARID1B,ARID1B,HGNC:18040,57492,66583,ENSG00000049618,7,2,0,2,0,0,0,2,0,8.9881989750392e-06,3.63182316665496e-05,1.74869146536534e-06,0.999949930200412,2.57805792586956e-10,2.85959393766085e-07,DDID,Gene expression regulation,Known NDD gene (AD),Coffin-Siris syndrome 1 (AD),NR,NR,FDR ≤ 0.01,FDR ≤ 0.01,Yes,Yes
SUV420H1,KMT5B,HGNC:24283,51111,55988,ENSG00000110066,6,0,1,1,0,0,0,1,0,4.00182216907489e-06,4.78130590300989e-06,5.43614364456956e-06,0.999930189531327,5.48345757689361e-10,2.85959393766085e-07,ASD,Gene expression regulation,Known NDD gene (AD),"Mental retardation, autosomal dominant 51 (AD)",NR,NR,FDR ≤ 0.01,FDR ≤ 0.01,Yes,Yes
DYRK1A,DYRK1A,HGNC:3091,1859,19044,ENSG00000157540,6,0,0,3,0,0,0,3,0,3.76031226527532e-06,6.95207712813551e-06,7.74410652532374e-06,0.999584541726647,8.21937851114285e-10,2.85959393766085e-07,DDID,Cytoskeleton,Known NDD gene (AD),"Mental retardation, autosomal dominant 7 (AD)",NR,NR,FDR ≤ 0.01,FDR ≤ 0.01,Yes,Yes
SLC6A1,SLC6A1,HGNC:11042,6529,13016,ENSG00000157103,0,1,7,1,0,0,0,1,0,2.71015676385351e-06,8.82604622715475e-06,9.63341678597101e-06,0.999301879165817,1.92085193306824e-09,2.85959393766085e-07,DDID,Neuronal communication,Known NDD gene (AD),Myoclonic-atonic epilepsy (AD),NR,NR,.,0.01 < FDR ≤ 0.05,Yes (missense),Yes
GRIN2B,GRIN2B,HGNC:4586,2904,12961,ENSG00000273079,4,0,2,3,0,3,0,6,0,4.94068305917252e-06,1.85221160681189e-05,2.27636565239508e-05,0.999994895762786,2.03757864116547e-08,2.85959393766085e-07,DDID,Neuronal communication,Known NDD gene (AD),"Epileptic encephalopathy, early infantile, 27 (AD); Mental retardation, autosomal dominant 6 (AD)",NR,NR,FDR ≤ 0.01,FDR ≤ 0.01,Yes,Yes
PTEN,PTEN,HGNC:9588,5728,11520,ENSG00000171862,3,1,3,0,0,0,0,0,0,2.11893181163014e-06,5.58732337124519e-06,4.14230704006482e-06,0.975506865848027,5.25709893950399e-08,2.85959393766085e-07,ASD,Neuronal communication,Known NDD gene (AD),"Macrocephaly/autism syndrome (AD); Cowden syndrome 1 (AD); Lhermitte-Duclos syndrome (AD); {Glioma susceptibility 2} (AD), {Meningioma} (AD)",NR,NR,0.01 < FDR ≤ 0.05,FDR ≤ 0.01,Yes,Yes
MED13L,MED13L,HGNC:22962,23389,50931,ENSG00000123066,5,0,0,0,0,0,0,0,0,9.0077481084941e-06,1.13981324067703e-05,6.8864123903882e-06,0.999999998677147,1.84155319423094e-06,2.85959393766085e-07,DDID,Gene expression regulation,Known NDD gene (AD),"Mental retardation and distinctive facial features with or without cardiac defects (AD); Transposition of the great arteries, dextro-looped 1 (AD)",NR,NR,.,.,.,Yes
GIGYF1,GIGYF1,HGNC:9126,64599,54402,ENSG00000146830,4,0,0,4,1,2,0,6,1,7.12815426866007e-06,1.02373635352627e-07,0,0.978704811680111,3.51319302251222e-06,2.85959393766085e-07,ASD,Other,Gene enriched for rare variants in ASD,.,.,none,.,0.01 < FDR ≤ 0.05,Yes,.
CHD2,CHD2,HGNC:1917,1106,15233,ENSG00000173575,4,1,2,1,0,1,0,2,0,1.10724838835119e-05,1.35013756330004e-05,1.34525218719402e-05,0.999999998845422,5.47023746218928e-06,2.85959393766085e-07,DDID,Gene expression regulation,Known NDD gene (AD),"Epileptic encephalopathy, childhood-onset (AD)",NR,NR,.,FDR ≤ 0.01,Yes,Yes
ANKRD11,ANKRD11,HGNC:21316,29123,98828,ENSG00000167522,4,0,0,3,0,0,0,3,0,9.05582043915516e-06,1.26143530269691e-05,2.19783796439658e-05,0.999999821632236,9.54518294931225e-06,2.85959393766085e-07,DDID,Gene expression regulation,Known NDD gene (AD),KBG syndrome (AD),NR,NR,.,.,Yes,Yes
ANK2,ANK2,HGNC:493,287,12263,ENSG00000145362,4,3,0,7,1,1,0,8,1,1.62561398036198e-05,3.64229856699779e-05,4.5592428897758e-07,0.999999999999808,1.42612279071715e-05,2.85959393766085e-07,ASD,Neuronal communication,Known NDD gene (AD),"Cardiac arrhythmia, ankyrin-B-related (AD); Long QT syndrome 4 (AD)","ClinGen: Sufficient evidence for haploinsufficiency pathogenicity, Haploinsufficiency phenotype: Autism spectrum disorder",NR,FDR ≤ 0.01,FDR ≤ 0.01,Yes,.
ASH1L,ASH1L,HGNC:19088,55870,19070,ENSG00000116539,5,0,1,1,0,0,0,1,0,1.40433606868861e-05,1.88605445860053e-05,8.37570429418597e-06,0.999999999999834,2.03612760843434e-05,2.85959393766085e-07,ASD,Gene expression regulation,Known NDD gene (AD),"Mental retardation, autosomal dominant 52 (AD)",NR,NR,0.05 < FDR ≤ 0.1,FDR ≤ 0.01,Yes,.
TLK2,TLK2,HGNC:11842,11011,16948,ENSG00000146872,3,0,2,1,0,0,0,1,0,6.25826912668728e-06,9.15648580879297e-06,1.0895622578177e-05,0.999999805897045,2.75760745496956e-05,2.85959393766085e-07,DDID,Gene expression regulation,Known NDD gene (AD),"Mental retardation, autosomal dominant 57 (AD)",NR,NR,.,.,.,.
DNMT3A,DNMT3A,HGNC:2978,1788,18772,ENSG00000119772,2,4,1,1,0,0,0,1,0,4.82367685617551e-06,2.11468496398549e-05,7.58412344683292e-06,7.7278751608327e-45,0.00110972766936686,2.85959393766085e-07,DDID,Gene expression regulation,Known NDD gene (AD),Tatton-Brown-Rahman syndrome (AD),NR,NR,.,0.01 < FDR ≤ 0.05,Yes (missense),.
DEAF1,DEAF1,HGNC:14677,10522,16398,ENSG00000177030,0,3,2,0,3,0,1,0,4,2.6080310424764e-06,1.42743953076418e-05,3.98181093289691e-07,0.000193157379315308,6.91544846281463e-05,2.85959393766085e-07,ASD,Gene expression regulation,Known NDD gene (AD),"Mental retardation, autosomal dominant 24 (AD); ?Dyskinesia, seizures, and intellectual developmental disorder (AR)",NR,NR,.,.,.,.
CTNNB1,CTNNB1,HGNC:2514,1499,17921,ENSG00000168036,3,1,0,2,0,0,0,2,0,3.93073643220946e-06,1.10930570807974e-05,7.68645994079336e-06,0.999812749503708,3.9849198871096e-05,5.7191878753217e-07,DDID,Gene expression regulation,Known NDD gene (AD),"Mental retardation, autosomal dominant 19 (AD); Exudative vitreoretinopathy 7 (AD)",NR,NR,.,.,.,Yes
KDM6B,KDM6B,HGNC:29012,23135,223272,ENSG00000132510,3,0,2,0,0,1,0,1,0,7.42666314291666e-06,4.90610685861491e-06,1.59147395544019e-05,0.999994424921105,0.000101252976624724,1.71575636259651e-06,ASD,Gene expression regulation,Gene enriched for rare variants in ASD,.,"Gene2Phenotype Database: AUTOSOMAL RECESSIVE MENTAL RETARDATION (biallelic), disease confidence: possible",none for autosomal dominant disorder,.,0.01 < FDR ≤ 0.05,Yes,.
DSCAM,DSCAM,HGNC:3039,1826,54128,ENSG00000171587,4,0,0,0,0,1,0,1,0,9.85428890221812e-06,4.24187397064952e-05,0,0.99999999983846,0.00013466435347903,1.71575636259651e-06,ASD,Neuronal communication,Known NDD gene (AD),.,"ClinGen: Sufficient evidence for haploinsufficiency pathogenicity, Haploinsufficiency phenotype: Autism",NR,.,FDR ≤ 0.01,Yes,.
SETD5,SETD5,HGNC:25566,55209,68652,ENSG00000168137,3,0,0,2,0,1,0,3,0,7.60227093855552e-06,8.65598319311394e-06,0,0.999999563778174,0.00018404445733724,4.00343151272519e-06,DDID,Gene expression regulation,Known NDD gene (AD),"Mental retardation, autosomal dominant 23 (AD)",NR,NR,0.05 < FDR ≤ 0.1,FDR ≤ 0.01,.,Yes
KCNQ3,KCNQ3,HGNC:6297,3786,11689,ENSG00000184156,0,0,4,0,0,0,0,0,0,4.3331300924429e-06,8.74578874305102e-06,1.00432978886243e-05,0.985604293672352,0.000236491057761617,4.57535030025736e-06,DDID,Neuronal communication,Known NDD gene (AD),"Seizures, benign neonatal, 2 (AD)",NR,NR,.,.,.,Yes
SRPR,SRPRA,HGNC:11307,6734,56749,ENSG00000182934,2,2,0,2,0,0,0,2,0,2.23097941591673e-06,1.23914341716069e-05,0,0.992611253840392,0.000288159061962766,4.57535030025736e-06,ASD,Other,Novel,.,.,none,.,.,.,.
KDM5B,KDM5B,HGNC:18039,10765,16531,ENSG00000117139,3,1,2,7,7,2,1,9,8,1.03841636355102e-05,1.0137453166242e-05,1.33671430044653e-06,5.09420142344633e-05,0.000345432038856758,1.42979696883043e-07,ASD,Gene expression regulation,Known NDD gene (AR); Gene enriched for rare variants in ASD,"Mental retardation, autosomal recessive 65 (AR)","Gene2Phenotype Database: AUTISM (monoallelic), disease confidence: possible",NR,.,FDR ≤ 0.01,.,Yes
WAC,WAC,HGNC:17327,51322,53902,ENSG00000095787,3,0,0,0,0,0,0,0,0,3.57055928890594e-06,7.71071140352802e-06,0,0.999891942627968,0.000408636141173403,6.29110666285387e-06,DDID,Gene expression regulation,Known NDD gene (AD),Desanto-Shinawi syndrome (AD),NR,NR,.,FDR ≤ 0.01,Yes,Yes
SHANK2,SHANK2,HGNC:14295,22941,72278,ENSG00000162105,3,0,0,2,0,0,0,2,0,8.72824004261026e-06,3.13136859047084e-05,0,0.999920169615752,0.000542025210895221,1.54418072633686e-05,ASD,Neuronal communication,Known NDD gene (AD),{Autism susceptibility 17} (AD),NR,NR,.,FDR ≤ 0.01,Yes,.
NRXN1,NRXN1,HGNC:8008,9378,50496,ENSG00000179915,3,1,0,1,0,0,0,1,0,7.25830502628954e-06,1.92986432924009e-05,2.25318404036904e-06,0.999948738356297,0.000671451880149796,1.60137260509008e-05,ASD,Neuronal communication,"Known NDD gene (AD, AR)","Pitt-Hopkins-like syndrome 2 (AR), {Schizophrenia, susceptibility to, 17} (AD)",ClinGen: Sufficient evidence for haploinsufficiency pathogenicity (neurodevelopmental phenotypes); Gene2Phenotype Database: AUTISM (monoallelic); PITT HOPKINS 2 (biallelic),NR,.,FDR ≤ 0.01,.,.
TBL1XR1,TBL1XR1,HGNC:29529,79718,71865,ENSG00000177565,2,0,1,1,0,0,0,1,0,2.83879651366828e-06,6.01733114917383e-06,5.80779445204499e-06,0.998821952425029,0.000870379086564989,2.51644266514155e-05,DDID,Gene expression regulation,Known NDD gene (AD),"Mental retardation, autosomal dominant 41 (AD); Pierpont syndrome (AD)",NR,NR,.,.,.,Yes
MYT1L,MYT1L,HGNC:7623,23040,14764,ENSG00000186487,2,0,2,1,0,0,0,1,0,5.39957367965225e-06,1.3905398549252e-05,1.56435061205337e-05,0.999963989377009,0.00136630235650404,3.66028024020589e-05,DDID,Gene expression regulation,Known NDD gene (AD),"Mental retardation, autosomal dominant 39 (AD)",NR,NR,0.05 < FDR ≤ 0.1,0.01 < FDR ≤ 0.05,Yes,Yes
BCL11A,BCL11A,HGNC:13221,53335,226541,ENSG00000119866,3,0,0,0,0,0,0,0,0,2.23551471930374e-06,0,0,0.828999684744843,0.00162692803100978,3.77466399771233e-05,DDID,Gene expression regulation,Known NDD gene (AD),Dias-Logan syndrome (AD),NR,NR,0.01 < FDR ≤ 0.05,0.01 < FDR ≤ 0.05,.,Yes
RORB,RORB,HGNC:10259,6096,12236,ENSG00000198963,2,0,1,0,0,0,0,0,0,2.62404971346641e-06,3.54213992381597e-06,5.753167525906e-06,0.998551700707594,0.00199238816626861,5.43322848155562e-05,ASD,Gene expression regulation,Novel,.,.,"Several cases with LoF variants or deletions reported (Rudolf 2016, PMID: 27352968 - neurodevelopmental disorders including epilepsy, especially in generalized epilepsies with predominant absence seizures)",.,.,.,.
RAI1,RAI1,HGNC:9834,10743,16525,ENSG00000108557,2,0,0,3,0,0,0,3,0,5.47408227040428e-06,9.32424769912402e-06,0,0.999136111876994,0.00234803570779102,5.49042036030884e-05,DDID,Gene expression regulation,Known NDD gene (AD),Smith-Magenis syndrome (AD),NR,NR,.,.,.,.
DYNC1H1,DYNC1H1,HGNC:2961,1778,18763,ENSG00000197102,1,3,4,7,0,0,0,7,0,2.23432548882797e-05,6.37702341784398e-05,8.26460125711628e-05,0.999999999999998,0.00272700335642173,5.83357163282814e-05,DDID,Cytoskeleton,Known NDD gene (AD),"Mental retardation, autosomal dominant 13 (AD); Charcot-Marie-Tooth disease, axonal, type 20 (AD); Spinal muscular atrophy, lower extremity-predominant 1 (AD)",NR,NR,.,.,Yes (missense),Yes
DPYSL2,DPYSL2,HGNC:3014,1808,54128,ENSG00000092964,0,0,3,0,0,0,0,0,0,2.52922068568136e-06,8.70417929637134e-06,8.63458212486256e-06,0.995558288769102,0.00324327541565193,7.83528738919073e-05,ASD,Cytoskeleton,Novel,.,.,none,.,.,.,.
AP2S1,AP2S1,HGNC:565,1175,27029,ENSG00000042753,0,0,2,2,0,0,0,2,0,1.01361894654881e-06,1.125926110566e-06,4.14465126480562e-06,0.919495985397116,0.00388128993863062,9.89419502430655e-05,ASD,Neuronal communication,Novel,"Hypocalciuric hypercalcemia, type III (AD)",Orphanet: Disease-causing germline mutation(s) in Familial hypocalciuric hypercalcemia type 3,"Multiple unrelated patients with hypercalcemia and AP2S1 mutations have learning disabilities/cognitive dysfunction (Szalat 2017, PMID: 28176280; Hannan 2015, PMID: 26082470; Hendy 2014, PMID: 24731014)",.,.,.,.
KMT2C,KMT2C,HGNC:13726,58508,66404,ENSG00000055609,4,3,1,1,0,0,0,1,0,2.31758107232927e-05,1.50777219828549e-05,2.07715551877491e-05,0.999999999999997,0.00448884390795469,9.89419502430655e-05,ASD,Gene expression regulation,Known NDD gene (AD),Kleefstra syndrome 2 (AD),NR,NR,.,FDR ≤ 0.01,Yes,.
PAX5,PAX5,HGNC:8619,5079,68193,ENSG00000196092,2,0,0,1,0,0,0,1,0,1.67350466866647e-06,6.26239262490068e-06,5.35252206246357e-06,0.984243988730267,0.0051072291001778,0.000106376894480984,ASD,Gene expression regulation,Gene enriched for de novo variants in ASD,"{Leukemia, acute lymphoblastic, susceptibility to, 3} (AD)",Orphanet: Major susceptibility factor in Precursor B-cell acute lymphoblastic leukemia,"O'Roak 2014, PMID: 25418537- sequencing of 64 candidate genes in 3486 ASD patients (Simons and TASC): gene significantly enriched for de novo variants",.,.,Yes,.
GABRB3,GABRB3,HGNC:4083,2562,17970,ENSG00000166206,1,2,0,1,0,0,0,1,0,2.43011230063526e-06,5.40684334632013e-06,1.00189054971247e-05,0.997073960271659,0.00674914762626484,0.000150986559908493,DDID,Neuronal communication,Known NDD gene (AD),"Epileptic encephalopathy, early infantile, 43 (AD); {Epilepsy, childhood absence, susceptibility to, 5} (AD)",NR,NR,0.01 < FDR ≤ 0.05,0.01 < FDR ≤ 0.05,.,Yes
SIN3A,SIN3A,HGNC:19353,25942,18947,ENSG00000169375,2,0,1,1,0,0,0,1,0,6.53210218005322e-06,1.72385707558697e-05,5.72565173596942e-06,0.99999994122779,0.0075842991375978,0.000160137260509008,DDID,Gene expression regulation,Known NDD gene (AD),Witteveen-Kolk syndrome (AD),NR,NR,.,.,.,.
MBD5,MBD5,HGNC:20444,55777,433926,ENSG00000204406,2,0,0,1,0,0,0,1,0,4.30228029987845e-06,0,0,0.999852333253027,0.00845793258896737,0.000176722905347441,DDID,Gene expression regulation,Known NDD gene (AD),"Mental retardation, autosomal dominant 1 (AD)",NR,NR,.,0.05 < FDR ≤ 0.1,.,.
MAP1A,MAP1A,HGNC:6835,4130,13490,ENSG00000166963,0,0,0,7,0,0,0,7,0,7.45319553186432e-06,5.91475663546896e-07,0,0.999688997602479,0.00930940657396657,0.000178438661710037,ASD,Cytoskeleton,Novel,.,.,"Limited evidence reported (Myers 2011, PMID: 21383861- excess of rare missense variants identified in both ASD and schizophrenia cohorts)",.,.,.,.
STXBP1,STXBP1,HGNC:11444,6812,13417,ENSG00000136854,0,0,3,0,0,0,0,0,0,3.2592968658306e-06,9.40725669056216e-06,1.14769945822939e-05,0.999882943227088,0.0101359056640701,0.000180726336860166,DDID,Neuronal communication,Known NDD gene (AD),"Epileptic encephalopathy, early infantile, 4 (AD)",NR,NR,.,.,.,Yes
CELF4,CELF4,HGNC:14015,56853,50759,ENSG00000101489,2,1,0,0,0,0,0,0,0,3.07618263921081e-06,6.91656877943058e-06,1.00455947456092e-05,0.974364730195216,0.0109446035401941,0.000185301687160423,ASD,Gene expression regulation,Novel,.,.,"Limited evidence reported (Halgren 2012, PMID: 22617346- complex rearrangement involving a de novo translocation and inversion interrupting CELF4 in a male with borderline IQ, developmental and behavioral disorders, myopia, obesity, and febrile seizures. Barone 2017, PMID: 28407444- 18q12.2 deletion involving CELF4 and KIAA1328 in a girl with syndromic ID and autism, inherited from her mildly affected mother.",.,.,.,.
PHF12,PHF12,HGNC:20816,57649,76571,ENSG00000109118,2,0,0,1,0,0,0,1,0,4.62162635737528e-06,5.85359559707294e-06,4.24631004742875e-06,0.999959675213551,0.0118175402239649,0.000207034601086646,DDID,Gene expression regulation,Novel,.,.,"Limited evidence reported (Xie 2016, PMID: 27247625- de novo microdeletion at 17q11.2 associated with developmental delay, short stature, microcephaly and dysmorphic features, one of seven genes listed as candidates)",.,.,.,.
TBR1,TBR1,HGNC:11590,10716,16522,ENSG00000136535,2,0,0,2,1,0,0,2,1,2.36696922184125e-06,0,0,0.993588037464593,0.0128645389749714,0.000280240205890763,ASD,Gene expression regulation,Known NDD gene (AD),Intellectual developmental disorder with autism and speech delay (AD),NR,NR,FDR ≤ 0.01,FDR ≤ 0.01,Yes,.
PPP2R5D,PPP2R5D,HGNC:9312,5528,242202,ENSG00000112640,1,0,2,0,0,0,0,0,0,3.40033839780068e-06,6.9166803628135e-06,9.29652538484725e-06,0.997520078948917,0.0139020836176155,0.000294538175579068,DDID,Gene expression regulation,Known NDD gene (AD),"Mental retardation, autosomal dominant 35 (AD)",NR,NR,.,.,.,Yes
TM9SF4,TM9SF4,HGNC:30797,9777,14268,ENSG00000101337,0,0,1,4,0,0,0,4,0,3.8618241345807e-06,1.14539322554707e-05,3.47475747965821e-06,0.999970772411386,0.0150407856686966,0.000359164998570203,ASD,Other,Novel,.,.,none,.,.,.,.
PHF21A,PHF21A,HGNC:24156,51317,231805,ENSG00000135365,2,0,0,0,0,0,0,0,0,3.60851434684035e-06,7.43540658400586e-06,4.78921269156385e-06,0.999675486100741,0.0162460088798687,0.000415784958535888,ASD,Gene expression regulation,Known NDD gene (AD),.,Gene2Phenotype database: POTOCKI-SHAFFER SYNDROME (monoallelic); MONDO: Potocki-Shaffer syndrome (contiguous gene deletion syndrome); Orphanet: Role in the phenotype of Potocki-Shaffer syndrome,NR,.,.,.,.
PRR12,PRR12,HGNC:29217,57479,66583,ENSG00000126464,2,0,0,1,0,0,0,1,0,5.56689810823076e-06,4.71386798288562e-05,1.43660573280191e-06,0.999969576883676,0.0174615353439387,0.00043751787246211,DDID,Neuronal communication,Novel,.,.,"Cordova-Fletes 2015, PMID: 26163108- de novo translocation disrupting PRR12 in a girl with ID, early onset seizures and neuropsychiatric disorders. Leduc 2018, PMID: 29556724- de novo LoF variants in PRR12 in 3 patients with ID, eye abnormalities, dysmorphic features, and neuropsychiatric problems, including autism in two.",.,.,.,.
SKI,SKI,HGNC:10896,6497,67337,ENSG00000157933,2,0,0,1,2,0,0,1,2,2.40630795482987e-06,7.7544441483302e-06,1.17827663727099e-05,0.981402099833324,0.0186607030306425,0.000449528167000286,ASD,Gene expression regulation,Known NDD gene (AD),Shprintzen-Goldberg syndrome (AD),NR,NR,.,.,.,.
ASXL3,ASXL3,HGNC:29357,80816,116748,ENSG00000141431,2,0,0,3,1,1,0,4,1,7.31298700466366e-06,0,0,0.999977048473461,0.0199505322367144,0.000509579639691164,DDID,Gene expression regulation,Known NDD gene (AD),Bainbridge-Ropers syndrome (AD),NR,NR,0.01 < FDR ≤ 0.05,.,Yes,Yes
SPAST,SPAST,HGNC:11233,6683,13211,ENSG00000021574,2,0,0,0,1,0,0,0,1,3.61357560143879e-06,2.35023068695089e-06,4.8899560829667e-06,0.99707471255289,0.0212044492909617,0.00051644266514155,ASD,Cytoskeleton,Known NDD gene (AD),"Spastic paraplegia 4, autosomal dominant (AD)",NR,NR,.,0.01 < FDR ≤ 0.05,Yes,.
SMARCC2,SMARCC2,HGNC:11105,6601,13135,ENSG00000139613,2,0,0,2,0,0,0,2,0,6.72963268269252e-06,2.16070100344423e-05,3.64314009418132e-06,0.999999989058527,0.0224205269153373,0.000517014583929082,ASD,Gene expression regulation,Known NDD gene (AD),.,.,"Definitive evidence: Machol 2019, PMID: 30580808- de novo variants in SMARCC2 cause an ID syndrome with prominent speech impairment, hypotonia, behavioral abnormalities, and dysmorphic features.",.,.,Yes,.
TRIP12,TRIP12,HGNC:12306,9320,13511,ENSG00000153827,2,0,2,1,0,0,0,1,0,1.03768489070912e-05,2.31879206665251e-05,9.62077404060965e-06,0.999999999999483,0.0235993990601586,0.000521018015441807,DDID,Gene expression regulation,Known NDD gene (AD),"Mental retardation, autosomal dominant 49 (AD)",NR,NR,.,FDR ≤ 0.01,.,.
CREBBP,CREBBP,HGNC:2348,1387,15450,ENSG00000005339,0,4,1,0,2,2,0,2,2,1.24203164740162e-05,3.45865591069876e-05,6.97130515423762e-06,0.999999999999794,0.0247479805370872,0.000525593365742065,DDID,Gene expression regulation,Known NDD gene (AD),Rubinstein-Taybi syndrome 1 (AD),NR,NR,.,.,.,Yes
TCF4,TCF4,HGNC:11634,6925,13495,ENSG00000196628,2,0,0,0,0,0,0,0,0,4.08692336627198e-06,7.63514149820311e-06,9.10916172474528e-06,0.999866544499818,0.0258777035205051,0.000532456391192451,DDID,Gene expression regulation,Known NDD gene (AD),"Pitt-Hopkins syndrome (AD); Corneal dystrophy, Fuchs endothelial, 3 (AD)",NR,NR,.,.,.,Yes
CACNA1E,CACNA1E,HGNC:1392,777,14309,ENSG00000198216,0,4,1,2,1,1,0,3,1,1.2338195188008e-05,2.87839755701326e-05,2.29586477153118e-05,0.999999999999934,0.0272115760691115,0.000673720331712897,DDID,Neuronal communication,Known NDD gene (AD),"Epileptic encephalopathy, early infantile, 69 (AD)",NR,NR,.,.,.,.
GNAI1,GNAI1,HGNC:4384,2770,21687,ENSG00000127955,0,0,2,0,0,0,0,0,0,1.62487906454492e-06,4.44165290547947e-06,3.94756772332492e-06,0.917528243665787,0.0285666053631595,0.00071661424077781,DDID,Other,Known NDD gene (AD),.,Gene2Phenotype Database: GNAI1 syndrome (monoallelic),NR,.,.,.,Yes
TCF20,TCF20,HGNC:11631,6942,319520,ENSG00000100207,2,0,0,1,0,0,0,1,0,6.37149425224595e-06,0,0,0.999977934276122,0.029926217275407,0.0007377752359165,DDID,Gene expression regulation,Known NDD gene (AD),.,"Gene2Phenotype Database: TCF20 syndrome (monoallelic); ClinGen: Sufficient evidence for dosage pathogenicity, Haploinsufficiency phenotype: complex neurodevelopmental disorder",NR,.,.,.,Yes
FOXP2,FOXP2,HGNC:13875,93986,75953,ENSG00000128573,1,0,1,0,0,1,0,1,0,5.44288468405133e-06,4.02724566636925e-06,1.37926950260447e-06,0.996178831092855,0.0312631445111665,0.000745210180154418,DDID,Gene expression regulation,Known NDD gene (AD),Speech-language disorder-1 (AD),NR,NR,.,.,.,.
NSD1,NSD1,HGNC:14234,64324,240084,ENSG00000165671,0,0,2,3,0,0,0,3,0,1.13672546070878e-05,8.39930774607156e-06,1.46297264178179e-05,0.999999999179163,0.0326007274243227,0.000760651987417787,DDID,Gene expression regulation,Known NDD gene (AD),Sotos syndrome 1 (AD),NR,NR,.,.,.,Yes
TCF7L2,TCF7L2,HGNC:11641,6934,407800,ENSG00000148737,2,0,0,0,1,0,1,0,2,4.08280668615844e-06,4.22527509058554e-06,9.65747073699303e-06,0.98960502908944,0.0339147060493667,0.00077209036316843,DDID,Gene expression regulation,Gene enriched for rare variants in ASD and de novo variants in NDD,"{Diabetes mellitus, type 2, susceptibility to} (AD)",.,"Lelieveld 2016, PMID: 27479843- exome-wide enrichment for de novo variants in neurodevelopmental disorders (including ID, ASD, epileptic encephalopathies and schizophrenia)",.,FDR ≤ 0.01,Yes,.
LDB1,LDB1,HGNC:6532,8861,12615,ENSG00000198728,2,0,0,1,1,0,0,1,1,1.99917912976626e-06,6.4820971661749e-06,6.16455441712127e-06,0.879454004833888,0.0353514109019892,0.000880754932799542,ASD,Gene expression regulation,Novel,.,.,none,.,.,.,.
PHF2,PHF2,HGNC:8920,5253,66475,ENSG00000197724,2,0,0,0,0,0,0,0,0,4.93500609491272e-06,2.63261430228417e-06,5.59489991659924e-07,0.994132137165918,0.0383405315622688,0.000984272233342865,ASD,Gene expression regulation,Gene enriched for rare variants in ASD,.,.,none,.,0.01 < FDR ≤ 0.05,Yes,.
KIAA0232,KIAA0232,HGNC:28992,9778,14268,ENSG00000170871,2,0,0,0,0,0,0,0,0,5.13495913514292e-06,0,0,0.99472089633487,0.0399175654755588,0.00104546754360881,ASD,Other,Novel,.,.,none,.,.,.,.
VEZF1,VEZF1,HGNC:12949,7716,16341,ENSG00000136451,0,0,1,3,0,0,0,3,0,1.97147936268476e-06,5.98474483594803e-06,2.57777865643918e-06,0.943031802518397,0.0415155367959489,0.00109064912782385,DDID,Gene expression regulation,Novel,.,.,none,.,.,.,.
IRF2BPL,IRF2BPL,HGNC:14282,64207,109135,ENSG00000119669,1,0,1,0,0,0,0,0,0,2.15135995756457e-06,1.53266769431275e-05,2.59854010256506e-06,0.968935346112199,0.0446806085726456,0.00113926222476408,DDID,Gene expression regulation,Known NDD gene (AD),"Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures (AD)",NR,NR,.,0.05 < FDR ≤ 0.1,.,.
ZMYND8,ZMYND8,HGNC:9397,23613,57423,ENSG00000101040,2,0,0,1,2,0,0,1,2,5.24141248911494e-06,1.62368944364027e-05,7.45100863790126e-06,0.999997106368404,0.0462333511375148,0.00114498141263941,ASD,Gene expression regulation,Novel,.,.,none,.,.,.,.
SATB1,SATB1,HGNC:10541,6304,23844,ENSG00000182568,1,1,0,2,0,1,0,3,0,4.12450936321298e-06,1.04541617351513e-05,1.01314444137303e-05,0.856613872020163,0.0478063978915827,0.00118787532170432,ASD,Gene expression regulation,Novel,.,.,none,.,.,.,.
RFX3,RFX3,HGNC:9984,5991,12018,ENSG00000080298,1,0,1,2,0,0,0,2,0,4.44131745298135e-06,8.5303475061699e-06,6.86168460190286e-06,0.999773274384127,0.0494140397916215,0.00124335144409494,ASD,Gene expression regulation,Novel,.,.,"Tabet 2015, PMID: 25844147- de novo intragenic deletion in a girl with ID, ASD and macrocephaly.   Sahoo 2011, PMID: 21792059- among individuals referred for microarray testing, 7 deletions encompassing RFX3, with sizes ranging from 177 kb to 3.5 Mb (2 de novo, 2 paternal, 3 inheritance unknown). The clinical features included autism, ID, and behavioral problems.  Walsh 2008, PMID: 18369103A- RFX3 deletion in a patient with schizophrenia (inheritance unknown).",.,.,.,.
SCN1A,SCN1A,HGNC:10585,6323,224796,ENSG00000144285,0,4,0,0,0,0,0,0,0,9.84953526182635e-06,2.93654402770816e-05,1.08057770528437e-05,0.999999999535395,0.0509900662296272,0.00124964255075779,ASD,Neuronal communication,Known NDD gene (AD),"Epileptic encephalopathy, early infantile, 6 (Dravet syndrome) (AD); Epilepsy, generalized, with febrile seizures plus, type 2 (AD); Febrile seizures, familial, 3A (AD); Migraine, familial hemiplegic, 3 (AD)",NR,NR,.,.,.,Yes
PPP5C,PPP5C,HGNC:9322,5536,26433,ENSG00000011485,0,3,0,0,0,0,0,0,0,2.87860596966333e-06,1.07135963871088e-05,1.2763561975639e-06,0.999092990117994,0.0526639536766339,0.00134172147555047,ASD,Other,Novel,.,.,none,.,.,.,.
TRIM23,TRIM23,HGNC:660,373,71991,ENSG00000113595,0,1,1,2,0,1,1,3,1,3.49741111044185e-06,9.15357540631566e-06,5.87785830715897e-07,0.0669671844650749,0.0545312130253719,0.000138443935926773,ASD,Other,Novel,.,.,none,.,.,.,.
TRAF7,TRAF7,HGNC:20456,84231,58875,ENSG00000131653,0,1,2,0,0,0,0,0,0,3.83099864469388e-06,1.1045037138777e-05,8.44809710053961e-06,0.460647228032184,0.0563543005765907,0.000456391192450672,DDID,Gene expression regulation,Known NDD gene (AD),"Cardiac, facial, and digital anomalies with developmental delay (AD)",NR,NR,.,.,.,.
ELAVL3,ELAVL3,HGNC:3314,1995,20238,ENSG00000196361,0,0,2,0,0,0,0,0,0,1.23817069025631e-06,7.40722309044117e-06,6.59650801413706e-06,0.822602583621291,0.0583249799949217,0.000514154989991421,ASD,Gene expression regulation,Novel,.,.,none,.,.,.,.
GRIA2,GRIA2,HGNC:4572,2891,12260,ENSG00000120251,1,1,1,1,0,0,0,1,0,3.95715875656627e-06,8.40990297608731e-06,9.43821936172948e-06,0.99550949045347,0.0604548867015123,0.00179067772376323,ASD,Neuronal communication,Novel,.,.,none,.,.,.,.
LRRC4C,LRRC4C,HGNC:29317,57689,52245,ENSG00000148948,0,1,1,1,0,0,0,1,0,1.52828311485778e-06,9.21485086356034e-06,1.45684669747798e-06,0.953730868705953,0.0625492873750691,0.00179982842436374,DDID,Neuronal communication,Novel,.,.,"Limited evidence reported (Maussion 2017, PMID: 27759917- LRRC4C deletion variants may be modifiers of neurodevelopmental disorders)",.,.,.,.
CACNA2D3,CACNA2D3,HGNC:15460,55799,226412,ENSG00000157445,2,0,0,0,0,0,1,0,1,7.0154120686306e-06,6.22519950931295e-06,0,0.998032255145607,0.0646145820233913,0.00181641406920217,ASD,Neuronal communication,Gene enriched for rare variants in ASD,.,.,none,0.01 < FDR ≤ 0.05,.,Yes,.
NUP155,NUP155,HGNC:8063,9631,14060,ENSG00000113569,0,0,0,4,0,1,0,5,0,7.82873366669017e-06,0,0,0.990594276419902,0.0666958360735749,0.001866742922505,ASD,Other,Novel,Atrial fibrillation 15 (AR),Orphanet: Disease-causing germline mutation(s) (loss of function) in Familial atrial fibrillation,none,.,.,.,.
KMT2E,KMT2E,HGNC:18541,55904,74125,ENSG00000005483,2,0,0,1,0,0,0,1,0,7.22265721816371e-06,9.15740907065383e-06,0,0.999999994702687,0.0688114729583291,0.00192965398913354,ASD,Gene expression regulation,Known NDD gene (AD),.,Gene2Phenotype Database: INTELLECTUAL DISABILITY (monoallelic),NR,.,0.05 < FDR ≤ 0.1,.,.
NR3C2,NR3C2,HGNC:7979,4306,14814,ENSG00000151623,1,0,0,3,0,0,0,3,0,4.61925022922202e-06,6.13071633463082e-06,3.6543215778716e-06,0.925088552607185,0.070931945334159,0.00196740062911067,DDID,Gene expression regulation,Gene enriched for rare variants in ASD,"Pseudohypoaldosteronism type I, autosomal dominant (AD); Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy (AD)","ClinGen: Sufficient evidence for dosage pathogenicity, Haploinsufficiency phentoype: Psuedoaldoseronism, type I, autosomal dominant; PHA1A; Orphanet: Disease-causing germline mutation(s) (loss of function) in Renal pseudohypoaldosteronism type 1, Disease-causing germline mutation(s) (gain of function) in Hypertension due to gain-of-function mutations in the mineralocorticoid receptor",none,0.05 < FDR ≤ 0.1,.,.,.
NACC1,NACC1,HGNC:20967,112939,71137,ENSG00000160877,1,0,0,2,0,0,0,2,0,1.584179759325e-06,1.18401391231411e-05,1.16474942443958e-05,0.964946936209724,0.0730206040521466,0.00198913354303689,DDID,Gene expression regulation,Known NDD gene (AD),"Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination (AD)",NR,NR,.,.,.,.
PTK7,PTK7,HGNC:9618,5754,11566,ENSG00000112655,1,1,1,0,1,0,0,0,1,4.46911065701657e-06,1.03870419353088e-05,5.46716294992905e-06,0.975879481016201,0.0751741594022528,0.00207148984844152,ASD,Cytoskeleton,Gene enriched for rare variants in ASD,.,.,"Lei 2019, PMID: 30689296- rare missense heterozygous PTK7 variants identified in patients with neural tube defects.",.,0.05 < FDR ≤ 0.1,.,.
PPP1R9B,PPP1R9B,HGNC:9298,84687,54378,ENSG00000108819,0,1,2,0,1,0,0,0,1,5.10137607343783e-06,2.1810592357287e-05,7.97171069128033e-06,0.997286913740502,0.0772839764759388,0.00207320560480412,ASD,Neuronal communication,Novel,.,.,"Limited evidence reported (Kemeny 2014, PMID: 25106685, Zahir 2009, PMID: 19449402- included in 17q21.33 microduplication)",.,.,.,.
GABRB2,GABRB2,HGNC:4082,2561,17970,ENSG00000145864,0,1,1,1,0,1,0,2,0,2.37277748257097e-06,4.10406177919909e-06,6.52974950338299e-06,0.940299230468594,0.0794846679766002,0.00218301401201029,DDID,Neuronal communication,Known NDD gene (AD),"Epileptic encephalopathy, infantile or early childhood, 2 (AD)",NR,NR,.,.,.,.
HDLBP,HDLBP,HGNC:4857,3069,227099,ENSG00000115677,0,3,0,1,0,0,0,1,0,6.07634273039421e-06,2.39644004334919e-05,2.56237796752272e-06,0.999998382970679,0.0816519919772198,0.00219788390048613,ASD,Gene expression regulation,Novel,.,.,"Felder 2009, PMID: 19365831- 1 of 3 genes downregulated in a patient with autism and 2q37 deletion syndrome, suggested as candidate.",.,.,.,.
TAOK1,TAOK1,HGNC:29259,57551,56447,ENSG00000160551,2,0,1,0,0,0,0,0,0,7.44309461105457e-06,1.4584962532812e-05,9.87504893121943e-06,0.999999739283145,0.0837970649678904,0.00222133257077495,DDID,Cytoskeleton,Novel,.,.,"Limited evidence reported (Xie 2016, PMID: 27247625- de novo microdeletion at 17q11.2 associated with developmental delay, short stature, microcephaly and dysmorphic features, one of seven genes listed as candidates)",.,.,.,.
TEK,TEK,HGNC:11724,7010,13637,ENSG00000120156,0,1,0,2,0,1,0,3,0,5.55115839360428e-06,1.48367355539379e-06,4.64728183238067e-06,0.999992784331617,0.0879961301577323,0.00224764083500143,ASD,Other,Novel,"Glaucoma 3, primary congenital, E (AD); Venous malformations, multiple cutaneous and mucosal (AD)","Gene2Phenotype Database: VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL (monoallelic); Orphanet: Disease-causing germline mutation(s) (loss of function) in Congenital glaucoma, Disease-causing germline mutation(s) (gain of function) in Mucocutaneous venous malformations",none,.,.,.,.
KCNMA1,KCNMA1,HGNC:6284,3778,11684,ENSG00000156113,0,0,3,0,1,0,0,0,1,5.70796650601329e-06,1.654099799077e-05,2.08858598107149e-05,0.999216602851545,0.0901161359157616,0.00233686016585645,ASD,Neuronal communication,"Known NDD gene (AD, AR)","Cerebellar atrophy, developmental delay, and seizures (AR); Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy (AD)",NR,NR,.,.,.,.
CORO1A,CORO1A,HGNC:2252,11151,17119,ENSG00000102879,0,0,2,0,0,0,0,0,0,1.92172635632714e-06,7.68589248119746e-06,8.08648862334042e-06,0.954491479297814,0.0921953498172861,0.00234086359736917,ASD,Cytoskeleton,Novel,Immunodeficiency 8 (AR),Orphanet: Disease-causing germline mutation(s) in Severe combined immunodeficiency due to CORO1A deficiency,none,.,.,.,.
NCOA1,NCOA1,HGNC:7668,8648,12479,ENSG00000084676,1,1,0,2,0,0,0,2,0,6.59713602063904e-06,4.30513659531155e-06,3.63489761221408e-06,0.999077342831501,0.0965270098077827,0.00250900772090363,ASD,Gene expression regulation,Novel,.,.,none,.,.,.,.
DIP2A,DIP2A,HGNC:17217,23181,11450,ENSG00000160305,2,1,0,0,1,2,2,2,3,7.0824834777242e-06,1.85630146223999e-05,6.84147660075966e-07,0.726099073608303,0.0986984636060859,0.00085902201887332,ASD,Neuronal communication,Gene enriched for rare variants in ASD,.,.,none,.,0.05 < FDR ≤ 0.1,.,.
